NFκB blocking was also reported for the tylophorine analogue in pancreatic [84] and hepatocellular [61] cancer cell lines, and thus we hypothesize a common mode of action regarding proliferation blocking in diverse cancer entities. Here, NFKB1 is linked to cancer.